Phase <scp>II</scp> trial of a novel chemotherapy regimen <scp>CVEP</scp> (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome <scp>(AIDS)</scp> ‐associated lymphomas-Reference-Cited by-同舟云学术

Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS) ‐associated lymphomas

Published:2022-11-02 Issue:4 Volume:200 Page:429-439
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sengar Manju¹^ORCID,Jain Hasmukh¹^ORCID,Shet Tanuja²,Sridhar Epari²,Gota Vikram³,Rangarajan Venkatesh⁴,Laskar Siddhartha S.⁵,Alahari Aruna⁶,Thorat Jayashree¹,Agarwal Archi⁴,Sharma Neha⁷,Gupta Himanshi⁸,Kannan Sadhana⁹,Kumar Shikhar¹⁰,Nayak Lingaraj¹⁰^ORCID,Menon Hari¹¹,Gujral Sumeet²,Bagal Bhausaheb¹⁰

Affiliation:

1. Department of Medical Oncology, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

2. Department of Pathology, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

3. Department of Clinical Pharmacology, ACTREC, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

4. Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

5. Department of Radiation Oncology, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

6. Department of General Medicine, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

7. Department of Medical Oncology Tata Memorial Centre Mumbai India

8. Hematology Cancer Consortium Mumbai India

9. Department of Biostatistics, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

10. Adult Hematolymphoid Unit, Tata Memorial Centre A CI of Homi Bhabha National Institute Mumbai India

11. Department of Haematology & Medical Oncology St. Johns National Academy of Health Sciences Bengaluru India

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18532

Reference32 articles.

1. Malignancies in HIV/AIDS

2. Multidrug resistance (MDR-1) expression in aids-related lymphomas

3. Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

4. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy

5. Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries